Filing Details
- Accession Number:
- 0001225208-17-017005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-06 18:45:28
- Reporting Period:
- 2017-11-02
- Accepted Time:
- 2017-11-06 18:45:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1271440 | S Christopher Holland | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Senior Vice President And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-02 | 20,410 | $97.69 | 47,401 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-11-02 | 17,832 | $136.37 | 65,233 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-02 | 38,242 | $334.04 | 26,991 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2017-11-02 | 17,832 | $0.00 | 17,832 | $136.37 |
| Common Stock | Option (Right to Buy) | Disposition | 2017-11-02 | 20,410 | $0.00 | 20,410 | $97.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,944 | 2023-12-11 | No | 4 | M | Direct | |
| 0 | 2022-12-12 | No | 4 | M | Direct |
Footnotes
- Includes 68.933 shares acquired under the Company's Employee Stock Purchase Plan from February 7, 2017 to August 7, 2017.
- Represents the weighted average sales price for price increments ranging from $333.69 to $334.38. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Of this option grant 17,832 options fully vested and the remaining options vest on December 11, 2017.
- Options fully vested and are currently exercisable.
Billionaire Hedge Funds
